Imricor Medical Systems Receives FDA Clearance; Shares Reach Four-Year High

MT Newswires Live

01/12

Imricor Medical Systems (ASX:IMR) received 510(k) clearance for its Vision-MR diagnostic catheter under the premarket notification process with the US Food and Drug Administration, according to a Monday filing with the Australian bourse.

The clearance allows the company to commercially market the catheter, which is designed to be used under real-time magnetic resonance imaging guidance, in the US, the filing said

The company expects to obtain multiple regulatory clearances and approvals this year, as per the filing.

Shares rose more than 25% in morning trade on Monday and earlier reached their highest since July 2021.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2602565517"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2602565517\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2602565517?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-12 07:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602565517","market":"sg","top_or_hot":-1,"title":"Imricor Medical Systems Receives FDA Clearance; Shares Reach Four-Year High","media":"MT Newswires Live","content":"<html><body><p> Imricor Medical Systems (ASX:IMR) received 510(k) clearance for its Vision-MR diagnostic catheter under the premarket notification process with the US Food and Drug Administration, according to a Monday filing with the Australian bourse.</p><p>The clearance allows the company to commercially market the catheter, which is designed to be used under real-time magnetic resonance imaging guidance, in the US, the filing said</p><p>The company expects to obtain multiple regulatory clearances and approvals this year, as per the filing.</p><p>Shares rose more than 25% in morning trade on Monday and earlier reached their highest since July 2021.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Imricor Medical Systems Receives FDA Clearance; Shares Reach Four-Year High</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nImricor Medical Systems Receives FDA Clearance; Shares Reach Four-Year High\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-01-12 07:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Imricor Medical Systems (ASX:IMR) received 510(k) clearance for its Vision-MR diagnostic catheter under the premarket notification process with the US Food and Drug Administration, according to a Monday filing with the Australian bourse.</p><p>The clearance allows the company to commercially market the catheter, which is designed to be used under real-time magnetic resonance imaging guidance, in the US, the filing said</p><p>The company expects to obtain multiple regulatory clearances and approvals this year, as per the filing.</p><p>Shares rose more than 25% in morning trade on Monday and earlier reached their highest since July 2021.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7007","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2602565517","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2602565517","pubTimestamp":1768174881,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Imricor Medical Systems  received 510 clearance for its Vision-MR diagnostic catheter under the premarket notification process with the US Food and Drug Administration, according to a Monday filing with the Australian bourse.The clearance allows the company to commercially market the catheter, which is designed to be used under real-time magnetic resonance imaging guidance, in the US, the filing saidThe company expects to obtain multiple regulatory clearances and approvals this year, as per the filing.Shares rose more than 25% in morning trade on Monday and earlier reached their highest since July 2021.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7007":"医疗保健设备","BK7508":"医药生物股","IMR.AU":"IMRICOR MEDICAL SYSTEMS-CDI","BK7503":"科技股"},"translate_title":"Imricor医疗系统公司获得FDA批准；股价创四年新高","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IMR.AU":1},"content_text":"Imricor Medical Systems (ASX:IMR) received 510(k) clearance for its Vision-MR diagnostic catheter under the premarket notification process with the US Food and Drug Administration, according to a Monday filing with the Australian bourse.The clearance allows the company to commercially market the catheter, which is designed to be used under real-time magnetic resonance imaging guidance, in the US, the filing saidThe company expects to obtain multiple regulatory clearances and approvals this year, as per the filing.Shares rose more than 25% in morning trade on Monday and earlier reached their highest since July 2021.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}